Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.

Autor: Hachmann NP; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Miller J; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Collier AY; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Ventura JD; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Yu J; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Rowe M; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Bondzie EA; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Powers O; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Surve N; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Hall K; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu., Barouch DH; Beth Israel Deaconess Medical Center, Boston, MA dbarouch@bidmc.harvard.edu.
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2022 Jul 07; Vol. 387 (1), pp. 86-88. Date of Electronic Publication: 2022 Jun 22.
DOI: 10.1056/NEJMc2206576
Databáze: MEDLINE